Pharmaceuticals LLC, a subsidiary of Pfizer Inc., a recall of levothyroxine sodium has begun at retail pharmacies due to complaints from pharmacists and patients of an “uncharacteristic odor” following the opening of some bottles.
“The odor is related to the oxygen-absorbing canister that is packaged in the 100-count and 1,000-count bottles. Pfizer has conducted a careful health assessment and has concluded that the odor is not likely to cause any adverse health consequences. However, the company discussed this situation with the FDA and decided, out of an abundance of caution, to voluntarily recall all strengths of Levoxyl to the retail level. There is no need for patients to return or discard the medication they have, as they may continue to take the medication in accordance with their health care provider’s prescribed directions,” the manufacturer wrote.
Levoxyl recall
Moderators: Rosie, Stanz, Jean, CAMary, moremuscle, JFR, Dee, xet, Peggy, Matthew, Gabes-Apg, grannyh, Gloria, Mars, starfire, Polly, Joefnh
Levoxyl recall
http://www.healio.com/endocrinology/thy ... until-2014